Cochrane Abstracts
Silymarin for adults with metabolic dysfunction‐associated steatotic liver disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Silymarin for Adults With Metabolic Dysfunction‐associated Steatotic Liver Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440795/all/Silymarin_for_adults_with_metabolic_dysfunction‐associated_steatotic_liver_disease.
Silymarin for adults with metabolic dysfunction‐associated steatotic liver disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440795/all/Silymarin_for_adults_with_metabolic_dysfunction‐associated_steatotic_liver_disease. Accessed February 10, 2026.
Silymarin for adults with metabolic dysfunction‐associated steatotic liver disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440795/all/Silymarin_for_adults_with_metabolic_dysfunction‐associated_steatotic_liver_disease
Silymarin for Adults With Metabolic Dysfunction‐associated Steatotic Liver Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440795/all/Silymarin_for_adults_with_metabolic_dysfunction‐associated_steatotic_liver_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Silymarin for adults with metabolic dysfunction‐associated steatotic liver disease
ID - 440795
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440795/all/Silymarin_for_adults_with_metabolic_dysfunction‐associated_steatotic_liver_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
